BioLargo (BLGO) Stock Price, News & Analysis

Company Overview

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

Key Stats

• Today's Range: $0.19 to $0.22
• 50-Day Range: $0.20 to $0.29
• 52-Week Range: $0.16 to $0.32
• Volume: 531,729 shs
• Average Volume: 276,031 shs
• Market Capitalization: $62.10 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BLGO Stock Analysis - Frequently Asked Questions

How have BLGO shares performed this year?

BioLargo's stock was trading at $0.19 on January 1st, 2025. Since then, BLGO shares have increased by 7.9% and is now trading at $0.2050.
View the best growth stocks for 2025 here.

How do I buy shares of BioLargo?

Shares of BLGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BioLargo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BioLargo investors own include Hydrofarm Holdings Group (HYFM), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Meta Platforms (META), Micron Technology (MU), Petróleo Brasileiro S.A. - Petrobras (PBR) and Clean Energy Fuels (CLNE).

Company Calendar

• Today: 5/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Construction
• Industry: Chemicals & allied products
• Sub-Industry: Chemicals
• Current Symbol: NASDAQ:BLGO
• CIK: 880242
• Web: www.biolargo.com
• Phone: (888) 400-2863
• Fax: 949-625-9819
• Employees: 30
• Year Founded: 1989

Profitability

• EPS (Most Recent Fiscal Year): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.50 million
• Net Margins: -11.45%
• Pretax Margin: -19.65%
• Return on Equity: -39.90%
• Return on Assets: -22.06%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 2.31
• Quick Ratio: 2.24

Sales & Book Value

• Annual Sales: $12.23 million
• Price / Sales: 5.08
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.01 per share
• Price / Book: 20.50

Miscellaneous

• Outstanding Shares: 302,949,000
• Free Float: 240,168,000
• Market Cap: $62.10 million
• Optionable: Not Optionable
• Beta: 0.19